Patents for C07F 5 - Compounds containing elements of the 3rd group of the periodic system (13,801) |
---|
12/19/2012 | CN102827193A Rare-earth complex nano luminescent material |
12/19/2012 | CN102824930A Method for preparing lithium chloride loaded strong acid ion exchange resin supported catalyst |
12/19/2012 | CN101962389B Rare-earth compound olefin monomer and preparation method and application thereof |
12/13/2012 | WO2012170330A1 Novel semiconducting alloy polymers formed from orthocarborane and 1,4-diaminobenzene |
12/13/2012 | WO2012170202A2 Catalyst systems comprising multiple non-coordinating anion activators and methods for polymerization therewith |
12/13/2012 | WO2012143080A3 Materials for organic electroluminescent devices |
12/13/2012 | WO2012071012A3 Bodipy structure fluorescence dye for neural stem cell probe |
12/13/2012 | US20120316364 Process for preparing triorgano borates with low alcohol content |
12/12/2012 | EP2533610A1 Composition for Charge-Transport Film and Ionic Compound, Charge-Transport Film and Organic Electroluminescence Device Using the Same, and Production Method of the Organic Electruminescence Device and Production Method of the Charge-Transport Film |
12/12/2012 | EP2533254A1 Reducing agent composition for conductive metal paste |
12/12/2012 | EP2531511A1 Fatty acid amide hydrolase inhibitors |
12/12/2012 | CN1919849B Method for producing a purified borazine compound, method for filling a container with a borazine compound and container for preserving a borazine compound |
12/12/2012 | CN102822131A Rare-earth metal complex |
12/12/2012 | CN102816178A Method and special device for separating trimethyl borate from carbinol mixture |
12/12/2012 | CN102816177A Quinacridone borate, and preparation method and application thereof |
12/12/2012 | CN102816176A Preparation method and use of trivalent europium ternary complex liquid material |
12/12/2012 | CN101891757B Preparation method of catalyst for producing cephalosporin |
12/12/2012 | CN101772507B Proteasome inhibitors |
12/12/2012 | CN101434613B Process for synthesizing Al-salicylic aldehyde acylhydrazone complexes |
12/11/2012 | US8329931 Organoaluminum compound |
12/11/2012 | US8329930 Aluminum complex and use thereof |
12/11/2012 | US8329929 Metal complex |
12/11/2012 | US8329771 Photobase generator |
12/11/2012 | CA2521245C Glycine-free antiperspirant salts with betaine for enhanced cosmetic products |
12/06/2012 | WO2012163490A1 Electrolyte formulations |
12/06/2012 | WO2012163489A1 Compounds containing hydrido-tricyano-borate anions |
12/06/2012 | WO2012163108A1 Rare earth europium coordination complex and application using same as light emitting material |
12/06/2012 | WO2012129452A8 Propynoic acid carbamoyl methyl-amides and pharmaceutical compositions and methods based thereon |
12/06/2012 | US20120310011 Preparation of boron crosslinking agents for fracturing fluids |
12/06/2012 | US20120309997 Enantiomerically Enriched Aminodiphosphines as Ligands for the Preparation of Catalysts for Asymmetric Synthesis |
12/06/2012 | US20120309982 Electrolyte formulations |
12/06/2012 | US20120309981 Process for the preparation of perfluoroalkylcyano- or perfluoroalkylcyanofluoroborates |
12/06/2012 | US20120308903 Novel Catalyst Mixtures |
12/06/2012 | US20120308823 Organically modified fine particles |
12/06/2012 | DE102011103754A1 Verfahren zur Herstellung von Dihydridodicyanoborat-Salzen A process for preparing salts Dihydridodicyanoborat |
12/05/2012 | EP2530100A1 Polymer compound and light-emitting device using same |
12/05/2012 | EP2529793A2 Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria |
12/05/2012 | CN1894261B Heterocyclic boronic acid compounds |
12/05/2012 | CN102807579A Quinacridone derivative borate and preparation method and application thereof |
12/05/2012 | CN102807578A Preparation method for lithium salt |
12/04/2012 | US8324416 Multifunctional chain shuttling agents |
12/04/2012 | US8323621 site-directed delivery of contrast agent; brain or breast cancer; 1,4,7,10 tetraazacyclododecane having variable chelating ions, phosphoester chains, and light harvesting moieties for changing imaging methods; conjugated to high affinity PBR ligand PK11195; bound to a PVA or a PEG delivery vehicle |
12/04/2012 | US8323362 Combustion modifier and method for improving fuel combustion |
11/29/2012 | WO2012161205A1 Cerium complex and organic electronic element comprising cerium complex |
11/29/2012 | WO2012131707A3 Crystalline form of bortezomib, preparation method and pharmaceutical composition there f |
11/29/2012 | US20120302434 Six-membered n-heterocyclic carbene-based catalysts for asymmetric reactions |
11/28/2012 | EP2527347A1 Proteasome inhibitors |
11/28/2012 | EP2527346A1 Photoluminescent nanoparticle, preparation, and application thereof |
11/28/2012 | EP2526107A1 Method for producing perfluoroalkyl cyanoborates or perfluoroalkyl cyanofluoroborates |
11/28/2012 | EP2526106A1 Compounds containing perfluoroalkyl-cyano-alkoxy-borate anions or perfluoroalkyl-cyano-alkoxy-fluoro-borate anions |
11/28/2012 | EP2526105A1 Electrolyte formulations |
11/28/2012 | EP2526104A1 Electrolyte formulations |
11/28/2012 | CN102803271A Process for hydrogenation of halogenoalkenes without dehalogenation |
11/28/2012 | CN102803270A Gadolinium complex, method for preparing same, and MRI contrast agent comprising same |
11/28/2012 | CN102796600A Preparation method of high-grade borate type automobile brake fluid |
11/28/2012 | CN102796142A Method for synthesizing HEDPA (hydroxyethylidenediphosphonic acid)-rare-earth complex |
11/28/2012 | CN102796133A Rare-earth europium complex and application thereof as luminescence material |
11/28/2012 | CN102070660B Synthesis method of rare earth coordination polymer with calcium ion fluorescent probe function |
11/28/2012 | CN101735253B Synthesis of amine boranes |
11/27/2012 | US8318983 System for controlling the reactivity of boronic acids |
11/27/2012 | US8318830 Photolatent catalysts based on organometallic compounds |
11/27/2012 | US8318699 Tumor necrosis factor inhibitors |
11/27/2012 | US8318450 Optically-detectable enzyme substrates and their method of use |
11/27/2012 | CA2523980C Process for production of phosphine-borane complexes |
11/22/2012 | WO2012157631A1 Aliphatic amine-coordinated cerium complex and element comprising aliphatic amine-coordinated cerium complex |
11/22/2012 | WO2012157580A1 Trifluoromethyl pyridine triol borate salt |
11/22/2012 | US20120296104 Cau-1-n3 organic-inorganic hybrid solid, equipped with an azide group, and process for its preparation |
11/22/2012 | US20120296103 Novel mil-53-al-n3 organic/inorganic hybrid solid provided with an azide function and method for manufacturing same |
11/22/2012 | US20120296096 Compounds containing perfluoroalkyl-cyano-alkoxy-borate anions or perfluoroalkyl-cyano-alkoxy-fluoro-borate anions |
11/22/2012 | US20120296095 Method for preparing organic/inorganic hybrid functionalized solids having a triazole ring |
11/22/2012 | US20120295902 Hetaryl-[1,8]naphthyridine derivatives |
11/22/2012 | US20120295875 Boron-containing small molecules as antiprotozoal agents |
11/22/2012 | US20120295874 Coferons and methods of making and using them |
11/22/2012 | US20120294885 Toll-like receptor-7 and -8 modulatory 1h imidazoquinoline derived compounds |
11/22/2012 | US20120294809 Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof |
11/22/2012 | US20120292571 Materials for organic electroluminescent devices |
11/22/2012 | DE112010004188T5 Metallkomplex mit mehrzähnigem Liganden Metal complex with multidentate ligands |
11/21/2012 | CN1680394B Process for producing compound, catalyst component, process for producing catalyst, and process for producing addition polymer |
11/21/2012 | CN102791709A Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof |
11/21/2012 | CN102791674A Compound having trimethylene structure, polymer compound containing unit that has trimethylene structure, and reactive compound having trimethylene structure |
11/21/2012 | CN102791661A Process for producing difluorocyclopropane compound |
11/21/2012 | CN102786544A Schiff base aluminum compound, preparation process of Schiff base aluminum compound and preparation process of polylactic acid |
11/21/2012 | CN102786543A Preparation methods for imidazole[1,2-a]pyridine-6-boric acid pinacol ester and derivatives thereof |
11/21/2012 | CN102786542A Preparation method and application for potassium quinoline thifluoroborate and potassium isoquinoline thifluoroborate |
11/21/2012 | CN102786541A Preparation method and application of potassium (iso)quinoline thifluoroborate |
11/21/2012 | CN102786540A Preparation method for coordination compound with reversible phase change dynamic single molecule |
11/21/2012 | CN101805364B Producing method of triethyl aluminium |
11/15/2012 | WO2012155042A2 Novel borate derivatives and their applications |
11/15/2012 | US20120289733 Novel borate derivatives and their applications |
11/15/2012 | US20120289728 Process for the preparation of indium chlordialkoxides |
11/15/2012 | US20120289699 Process for Preparing and Purifying Bortezomib |
11/15/2012 | US20120289686 Boron-containing small molecules |
11/15/2012 | US20120289632 Novel nucleating agents for polyolefins based on metal salts |
11/14/2012 | EP2522679A1 Phenylboronic acid monomer and phenylboronic acid polymer |
11/14/2012 | EP2522648A1 Process for producing difluorocyclopropane compound |
11/14/2012 | EP2521725A1 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof |
11/13/2012 | US8309753 Method for producing optically active cyanohydrin compound |
11/13/2012 | US8309749 Process of making aluminoxane and catalysts containing thus prepared aluminoxane |
11/13/2012 | US8309741 Benzocarbazole-intercalated layered double hydroxides composite luminescent material and its preparation method |
11/13/2012 | US8309053 Labeled fatty acid analogs; tissue-targeted therapy; tomography; block the catabolic pathway, thus trapping these analogs in a virtually unmodified form in the tissues of interest such as heart, liver, or tumor; endo-vinylic variants of cycloalkyl-substituted heptadecanoic acid for example |